More than 1 million Americans live with tremors, slowed movement and speech changes caused by Parkinson's disease—a ...

Clene has requested a Type C meeting with the FDA and anticipates the meeting will occur during the first quarter of 2026 to present the full dataset. The Company plans to submit an NDA under the ...

Patients with untreated RLS showed the highest Parkinson's incidence (2.1%) and an earlier onset of the disease.

STOCKHOLM, SE / ACCESS Newswire / December 3, 2025 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a pharmaceutical ...

Researchers from Korea University Ansan Hospital and collaborators report that patients with restless legs syndrome (RLS) ...